GoldHaven Resources Corp.: GoldHaven Resources Acquires Claims Within Magno Project

GoldHaven Resources Corp. ("GoldHaven" or the "Company") (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to announce that it ...

SEALSQ and IC'Alps Unify Expertise to Deliver Integrated Post-Quantum Cybersecurity and Functional Safety for Autonomous Vehicles

SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and ...

TappAlpha's TDAQ Surpasses $25 Million AUM in Under Two Months, Outpacing Nasdaq 100 in Performance

TappAlpha, a fintech-powered ETF issuer focused on making advanced investment strategies accessible, is proud to announce ...

Sokoman Minerals Corp.: Sokoman Minerals Closes $26 Million "Bought Deal" Private Placement, including Full Exercise of Over-Allotment

Sokoman Minerals Corp. (TSXV: SIC) (OTCQB: SICNF) ("Sokoman" or the "Company") is pleased to announce that it has closed its ...

Karolinska Development AB (publ): Karolinska Development's portfolio company BOOST Pharma presents positive long-term data for its cell-based treatment of Osteogenesis imperfecta

STOCKHOLM, SWEDEN, October 31, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company BOOST Pharma has presented new long-term data from the BOOSTB4 phase ...

BioStem Technologies, Inc.: BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain Allograft in Diabetic Foot Ulcers

BioStem Technologies, Inc. ("BioStem" or the "Company") (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization ...

Castellum, Inc. Announces the Award of a $66.2 million Full and Open Contract to its SSI Subsidiary

Castellum, Inc. (NYSE-American: CTM) ("Castellum" or "CTM"), a cybersecurity, electronic warfare, and software engineering services company focused on the ...

Adagene Inc.: Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA ...

Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug ...

Oppenheimer Holdings Inc. Reports Third Quarter 2025 Earnings

NEW YORK, Oct. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings ...

Ramaco Resources, Inc.: Ramaco and U. S. Department of Energy's (DOE) National Energy Technology Laboratory (NETL) Execute Far-Reaching Strategic Agreement on Rare Earths and ...

Ramaco Resources, Inc. (NASDAQ: METC, METCB) ("Ramaco" or the "Company") is proud to announce the signing of an Umbrella ...

Federal Realty Investment Trust Reports Third Quarter 2025 Results

Federal Realty Investment Trust (NYSE:FRT) today reported its results for the third quarter ended September 30, ...

TXNM Energy, Inc.: TXNM Energy Reports Third Quarter 2025 Results

GAAP earnings of $1.22 per diluted share 2025 third quarter ongoing earnings of $1.33 per diluted share Proposed transaction with Blackstone ...